APA

Silan C., Dogan O. T., Silan F., Kukulguven F. M., Asgun H. F., Ozdemir S., Uludag A., Atik S., Gungor B., Akdur S., Aksulu H. E. & Ozdemir O. (20130404). The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

Chicago

Silan Coskun, Dogan Omer Tamer, Silan Fatma, Kukulguven Fatma Mutlu, Asgun Halil Fatih, Ozdemir Semra, Uludag Ahmet, Atik Sinem, Gungor Buket, Akdur Seçil, Aksulu Hakki Engin and Ozdemir Oztürk. 20130404. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

Harvard

Silan C., Dogan O. T., Silan F., Kukulguven F. M., Asgun H. F., Ozdemir S., Uludag A., Atik S., Gungor B., Akdur S., Aksulu H. E. and Ozdemir O. (20130404). The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports.

MLA

Silan Coskun, Dogan Omer Tamer, Silan Fatma, Kukulguven Fatma Mutlu, Asgun Halil Fatih, Ozdemir Semra, Uludag Ahmet, Atik Sinem, Gungor Buket, Akdur Seçil, Aksulu Hakki Engin and Ozdemir Oztürk. The prevalence of VKORC1 1639 G>A and CYP2C9*2*3 genotypes in patients that requiring anticoagulant therapy in Turkish population. : Molecular biology reports. 20130404.